Molecular Docking Study For Adenosine Monophosphate-Activated Protein Kinase Agonist From Syzygium Cumini For Treatment Of Diabetes Mellitus-Type 2. Journal of Pharmaceutical Negative Results. Published online January 1, 2023:1078-1085. doi:10.47750/pnr.2023.14.S02.132